- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03722264
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients. A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primers are a type of 'glue' routinely used in orthodontics to attach brackets (metallic components) to the teeth. OpalSeal is a fluoride-releasing primer that has the potential to reduce cavities in patients receiving braces.
Orthodontic patients are at particular risk of developing two types of early carious lesions (decay):
- Around the brackets called White Spot Lesions and
- Along the sides of the teeth after slenderization procedure called inter-proximal reduction (IPR).
Our research questions are:
- Can OpalSeal offer protection against white spot lesions (WSL) around the brackets?
- Can OpalSeal offer protection against decay on the sides of teeth following IPR?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- School of Dentistry, Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes
- Such teeth should be free of any developmental defects
Exclusion Criteria:
- Patients under 10 years of age
- Patients with defective teeth
- Those who cannot provide consent/assent OR not able to follow research protocols
- Protected population (prisoners)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: OpalSeal
OpalSeal will be applied
|
OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets
|
Placebo Comparator: Transbond XT
TransbondXT will be applied
|
Transbond is a primer used to bond orthodontic brackets that does not contain fluoride
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Loss of Mineral Density in the Enamel
Time Frame: Time from initial bonding to extraction (max 90 days)
|
Teeth will be subjected to microCT to assess the extent of demineralization.
Loss of mineral density will be measured as depth of lesions
|
Time from initial bonding to extraction (max 90 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surface Topography and Hardness
Time Frame: Time from initial bonding to extraction (max 90 days)
|
Scanning electron microscopy and atomic force microscopy will be used to evaluate the protective effect of OpalSeal
|
Time from initial bonding to extraction (max 90 days)
|
Retention of OpalSeal
Time Frame: Time from initial bonding to extraction (max 90 days)
|
The protective effects of OpalSeal is subject to its retention at the site of application.
Since OpalSeal fluoresces under black light, its retention will be evaluated
|
Time from initial bonding to extraction (max 90 days)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Parthasarathy Madurantakam, DDS, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20011025
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cavities of Teeth
-
Cairo UniversityRecruitingProximal Cavities of Posterior TeethEgypt
-
3MActive, not recruitingCavities of Teeth | Dental DecayUnited States
-
Erica TeixeiraTokuyama Dental CorporationActive, not recruiting
-
University of MichiganUniversity of Iowa; NYU Langone Health; National Institute of Dental and Craniofacial...CompletedCavities of TeethUnited States
-
University of MinnesotaActive, not recruitingCavities of Teeth | CavityUnited States
-
Maha A. BahammamKing Abdulaziz UniversityCompletedGingivitis | Plaque | Tooth Decay | Cavities of TeethSaudi Arabia
-
Lannett Company, Inc.TerminatedDiagnostic | Procedures and Surgeries on or Through Accessible Mucous Membranes | of the Nasal CavitiesUnited States
-
Izmir Katip Celebi UniversityCompleted
-
3MTerminatedRestoration of Posterior TeethUnited States
-
Cairo UniversityNot yet recruiting